LHX Stock Analysis: L3Harris Technologies | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 55.928m USD | 12M Return: 14.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 359M
EPS Trend: -64.7%
Qual. Beats: 5
Rev. Trend: 93.8%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
L3Harris Technologies (NYSE: LHX) is a large-cap U.S. aerospace and defense company headquartered in Melbourne, Florida, that delivers mission-critical solutions to government and commercial customers worldwide. Founded in 1895 and formerly known as Harris Corporation, the company adopted its current name in June 2019 following the merger of Harris and L3 Technologies. It operates through three reporting segments: Space & Mission Systems (satellites, payloads, missile warning, and civil government programs), Missile Solutions (propulsion and hypersonic missile technologies), and Communications & Spectrum Dominance (tactical radios, satellite terminals, night vision optics, and public safety communications).
As a prime and sub-tier contractor in the Aerospace & Defense sector, L3Harris derives a substantial share of its revenue from long-cycle U.S. Department of Defense programs, with additional exposure to federal agencies, allied governments, and commercial customers. The industry is characterized by multi-year program backlogs, high regulatory and certification barriers, and sensitivity to U.S. and allied defense budget trends.
- Missile Solutions segment revenue accelerates on hypersonic demand
- DoD budget growth expands multi-year backlog visibility
- Fixed-price contract execution pressures consolidated operating margins
| Net Income: 1.73b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.76 > 1.0 |
| NWC/Revenue: 1.30% < 20% (prev 0.69%; Δ 0.61% < -1%) |
| CFO/TA 0.07 > 3% & CFO 3.05b > Net Income 1.73b |
| Net Debt (11.5b) to EBITDA (3.85b): 2.99 < 3 |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (188.2m) vs 12m ago -0.46% < -2% |
| Gross Margin: 25.26% > 18% (prev 26.01%; Δ -0.75% > 0.5%) |
| Asset Turnover: 54.41% > 50% (prev 51.51%; Δ 2.90% > 0%) |
| Interest Coverage Ratio: 4.54 > 6 (EBIT TTM 2.65b / Interest Expense TTM 583.0m) |
| A: 0.01 (Total Current Assets 8.89b - Total Current Liabilities 8.60b) / Total Assets 41.4b |
| B: 0.11 (Retained Earnings 4.42b / Total Assets 41.4b) |
| C: 0.06 (EBIT TTM 2.65b / Avg Total Assets 41.3b) |
| D: 0.91 (Book Value of Equity 19.7b / Total Liabilities 21.7b) |
| Altman-Z'' = 1.78 = BBB |
| DSRI: 0.96 (Receivables 5.44b/5.35b, Revenue 22.5b/21.2b) |
| GMI: 1.03 (GM 26.01% / 25.26%) |
| AQI: 0.96 (AQ_t 0.72 / AQ_t-1 0.75) |
| SGI: 1.06 (Revenue 22.5b / 21.2b) |
| TATA: -0.03 (NI 1.73b - CFO 3.05b) / TA 41.4b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of July 28, 2026, the stock is trading at USD 303.48 with a total of 1,196,219 shares traded. Over the past week, the price has changed by +8.17%, over one month by +4.87%, over three months by -4.91% and over the past year by +14.45%.
Current recommended Stop Loss: 292.50 (which is 3.6% or 1.3 ATR below the current price).
L3Harris Technologies has received a consensus analysts rating of 4.38. Therefore, it is recommended to buy LHX.
- StrongBuy: 13
- Buy: 3
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 375.1 | 23.6% |
P/E Trailing = 32.5607
P/E Forward = 26.0417
P/S = 4.3503
P/B = 2.8367
P/EG = 1.6928
Revenue TTM = 22.5b USD
EBIT TTM = 2.65b USD
EBITDA TTM = 3.85b USD
Long Term Debt = 9.19b USD (from longTermDebt, last quarter)
Short Term Debt = 2.17b USD (from shortTermDebt, last quarter)
Debt = 12.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 736.0m
Net Debt = 11.5b USD (calculated: Debt 12.1b - CCE 590.0m)
Enterprise Value = 67.4b USD (55.9b + Debt 12.1b - CCE 590.0m)
Interest Coverage Ratio = 4.54 (Ebit TTM 2.65b / Interest Expense TTM 583.0m)
EV/FCF = 26.05x (Enterprise Value 67.4b / FCF TTM 2.59b)
FCF Yield = 3.84% (FCF TTM 2.59b / Enterprise Value 67.4b)
FCF Margin = 11.52% (FCF TTM 2.59b / Revenue TTM 22.5b)
Net Margin = 7.71% (Net Income TTM 1.73b / Revenue TTM 22.5b)
Gross Margin = 25.26% ((Revenue TTM 22.5b - Cost of Revenue TTM 16.8b) / Revenue TTM)
Gross Margin QoQ = 24.41% (prev 25.60%)
Tobins Q-Ratio = 1.63 (Enterprise Value 67.4b / Total Assets 41.4b)
Interest Expense / Debt = 4.82% (Interest Expense 583.0m / Debt 12.1b)
Taxrate = 16.00% (330.0m / 2.06b)
NOPAT = 2.22b (EBIT 2.65b * (1 - 16.00%))
Current Ratio = 1.03 (Total Current Assets 8.89b / Total Current Liabilities 8.60b)
Debt / Equity = 0.61 (Debt 12.1b / totalStockholderEquity, last quarter 19.7b)
Debt / EBITDA = 2.99 (Net Debt 11.5b / EBITDA 3.85b)
Debt / FCF = 4.44 (Net Debt 11.5b / FCF TTM 2.59b)
Total Stockholder Equity = 19.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.19% (Net Income 1.73b / Total Assets 41.4b)
RoE = 8.87% (Net Income TTM 1.73b / Total Stockholder Equity 19.5b)
RoCE = 9.21% (EBIT 2.65b / Capital Employed (Equity 19.5b + L.T.Debt 9.19b))
RoIC = 6.47% (NOPAT 2.22b / Invested Capital 34.4b)
WACC = 6.11% (E(55.9b)/V(68.0b) * Re(6.56%) + D(12.1b)/V(68.0b) * Rd(4.82%) * (1-Tc(0.16)))
Discount Rate = 6.56% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.19 | Cagr: -0.70%
[DCF] Terminal Value 77.83% ; FCFF base≈2.46b ; Y1≈2.80b ; Y5≈4.04b
[DCF] Fair Price = 265.2 (EV 60.9b - Net Debt 11.5b = Equity 49.4b / Shares 186.3m; r=8.35% [WACC [floored]]; 5y FCF grow 14.10% → 2.50% )
EPS Correlation: -64.74 | EPS CAGR: -4.31% | SUE: 4.0 | # QB: 5
Revenue Correlation: 93.83 | Revenue CAGR: 7.30% | SUE: 3.50 | # QB: 1
EPS current Quarter (2026-06-30): EPS=2.83 | Chg30d=-0.22% | Revisions=+0% | Analysts=11
EPS next Quarter (2026-09-30): EPS=3.01 | Chg30d=-0.59% | Revisions=+0% | Analysts=11
EPS current Year (2026-12-31): EPS=11.76 | Chg30d=-0.06% | Revisions=+40% | GrowthEPS=+9.6% | GrowthRev=+7.8%
EPS next Year (2027-12-31): EPS=13.63 | Chg30d=-0.13% | Revisions=+31% | GrowthEPS=+15.9% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: +39% (up=18, down=7)